To amend the Federal Food, Drug, and Cosmetic Act regarding the patient medication information required to be included in the labeling of prescription drugs, and for other purposes.
Summary
What This Bill Does
The bill requires findings Congress finds the following: Prescription medications are important to the health and well-being of the American public, provides patient medication information for prescription drugs Chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and provides patient medication information for prescription drugs. It relies on compliance mandates, product standards, appropriations, and reporting requirements. The main policy areas are Healthcare Consumers, Foreign Policy, Housing, and Healthcare.
Who Benefits and How
Researchers and scientific institutions affected by the bill could gain revenue opportunities, Patients and health care consumers affected by the bill could gain revenue opportunities, and Homeowners, tenants, or housing market participants affected by the bill could gain revenue opportunities.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Homeowners, tenants, or housing market participants affected by the bill would take on compliance duties.
Key Provisions
- Requires findings Congress finds the following: Prescription medications are important to the health and well-being of the American public.
- Provides patient medication information for prescription drugs Chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
- Provides patient medication information for prescription drugs.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires findings Congress finds the following: Prescription medications are important to the health and well-being of the American public, provides patient medication information for prescription drugs Chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and provides patient medication information for prescription drugs.
Key Policy Areas
Healthcare Consumers, Foreign Policy, Housing, Healthcare
Primary Purpose
The bill requires findings Congress finds the following: Prescription medications are important to the health and well-being of the American public, provides patient medication information for prescription drugs Chapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C, and provides patient medication information for prescription drugs.
Policy Domains
Whole bill
Identified Gains
- Researchers and scientific institutions affected by the bill
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Foreign businesses and cross-border trade participants affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Homeowners, tenants, or housing market participants affected by the bill
- Foreign businesses and cross-border trade participants affected by the bill
- Disaster response agencies and disaster-affected communities
Sponsors
Legislative Progress
IntroducedMr. Carter of Georgia (for himself, Mr. Golden of Maine, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology